566 related articles for article (PubMed ID: 11346731)
1. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas.
Onofre MA; Sposto MR; Navarro CM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):535-40. PubMed ID: 11346731
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer.
Warnakulasuriya KA; Johnson NW
J Oral Pathol Med; 1996 Mar; 25(3):97-103. PubMed ID: 9148038
[TBL] [Abstract][Full Text] [Related]
3. The utility of toluidine blue staining and brush cytology as adjuncts in clinical examination of suspicious oral mucosal lesions.
Güneri P; Epstein JB; Kaya A; Veral A; Kazandı A; Boyacioglu H
Int J Oral Maxillofac Surg; 2011 Feb; 40(2):155-61. PubMed ID: 21112183
[TBL] [Abstract][Full Text] [Related]
4. Toluidine blue staining for detection of oral premalignant lesions and carcinomas.
Miller RL; Simms BW; Gould AR
J Oral Pathol; 1988 Feb; 17(2):73-8. PubMed ID: 3134535
[TBL] [Abstract][Full Text] [Related]
5. The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia.
Martin IC; Kerawala CJ; Reed M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Apr; 85(4):444-6. PubMed ID: 9574954
[TBL] [Abstract][Full Text] [Related]
6. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions.
Ram S; Siar CH
Int J Oral Maxillofac Surg; 2005 Jul; 34(5):521-7. PubMed ID: 16053872
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions.
Nagaraju K; Prasad S; Ashok L
Indian J Dent Res; 2010; 21(2):218-23. PubMed ID: 20657091
[TBL] [Abstract][Full Text] [Related]
8. A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions.
Rahman F; Tippu SR; Khandelwal S; Girish KL; Manjunath BC; Bhargava A
Quintessence Int; 2012 Jan; 43(1):51-9. PubMed ID: 22259809
[TBL] [Abstract][Full Text] [Related]
9. Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions.
Chainani-Wu N; Madden E; Cox D; Sroussi H; Epstein J; Silverman S
Oral Dis; 2015 Oct; 21(7):879-85. PubMed ID: 26173924
[TBL] [Abstract][Full Text] [Related]
10. Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions.
Gupta A; Singh M; Ibrahim R; Mehrotra R
Acta Cytol; 2007; 51(5):788-94. PubMed ID: 17910350
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of oral exfoliative cytology for the diagnosis of oral squamous dysplasia and carcinoma].
Navone R; Marsico A; Reale I; Pich A; Broccoletti R; Pentenero M; Gandolfo S
Minerva Stomatol; 2004 Mar; 53(3):77-86. PubMed ID: 15107778
[TBL] [Abstract][Full Text] [Related]
12. Potentially malignant epithelial oral lesions: discrepancies between clinical and histological diagnosis.
Onofre MA; Sposto MR; Navarro CM; Motta ME; Turatti E; Almeida RT
Oral Dis; 1997 Sep; 3(3):148-52. PubMed ID: 9467356
[TBL] [Abstract][Full Text] [Related]
13. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment.
Awan Kh; Yang Y; Morgan P; Warnakulasuriya S
Oral Dis; 2012 Nov; 18(8):728-33. PubMed ID: 22524200
[TBL] [Abstract][Full Text] [Related]
14. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
[TBL] [Abstract][Full Text] [Related]
15. Oral potentially malignant disorders: A comprehensive review on clinical aspects and management.
Warnakulasuriya S
Oral Oncol; 2020 Mar; 102():104550. PubMed ID: 31981993
[TBL] [Abstract][Full Text] [Related]
16. Toluidine blue staining in the detection of oral precancerous and malignant lesions.
Silverman S; Migliorati C; Barbosa J
Oral Surg Oral Med Oral Pathol; 1984 Apr; 57(4):379-82. PubMed ID: 6200814
[TBL] [Abstract][Full Text] [Related]
17. Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma.
Pindborg JJ; Reibel J; Holmstrup P
J Oral Pathol; 1985 Oct; 14(9):698-708. PubMed ID: 3932623
[TBL] [Abstract][Full Text] [Related]
18. Reliability of toluidine blue vital staining in detection of potentially malignant oral lesions--time to reconsider.
Upadhyay J; Rao NN; Upadhyay RB; Agarwal P
Asian Pac J Cancer Prev; 2011; 12(7):1757-60. PubMed ID: 22126560
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of autofluorescence to identify suspicious oral lesions--a prospective, blinded clinical trial.
Koch FP; Kaemmerer PW; Biesterfeld S; Kunkel M; Wagner W
Clin Oral Investig; 2011 Dec; 15(6):975-82. PubMed ID: 20714910
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic efficiency of differentiating small cancerous and precancerous lesions using mucosal brush smears of the oral cavity--a prospective and blinded study.
Koch FP; Kunkel M; Biesterfeld S; Wagner W
Clin Oral Investig; 2011 Oct; 15(5):763-9. PubMed ID: 20593209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
